Interdigitating dendritic cell sarcoma of low extremitis resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation

Česká verzia

Authors: Z. Adam ¹; K. Veselý ²; M. Krejčí ¹; L. Pour ¹; F. Fakan ³; R. Soumarová ⁴; J. Neubauer ⁵; J. Vaníček ⁶; J. Černý ⁷; L. Křen ⁸; K. Bolčák ⁹; L. Šmardová ¹; R. Hájek ¹; J. Mayer ¹
Authors place of work: Interní hematoonkologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jiří Vorlíček, CSc. ¹; I. patologicko‑anatomický ústav Lékařské fakulty MU a FN u sv. Anny Brno, přednostka doc. MUDr. Markéta Hermanová, Ph. D. ²; Šiklův patologicko‑anatomický ústav Lékařské fakulty UK a FN Plzeň, přednosta prof. MUDr. Michal Michal ³; Komplexní onkologické centrum J. G. Mendela Nový Jičín, přednostka doc. MUDr. Renata Soumarová, Ph. D. ⁴; Radiologická klinika Lékařské fakulty MU a FN Brno, přednosta prof. MUDr. Vlastimil A. Válek, CSc. ⁵; Klinika zobrazovacích metod Lékařské fakulty MU a FN u sv. Anny Brno, přednosta doc. MUDr. Petr Krupa, CSc. ⁶; I. ortopedická klinika Lékařské fakulty MU a FN u sv. Anny Brno, přednosta doc. MUDr. Pavel Janíček, CSc. ⁷; Ústav patologické anatomie Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jirka Mačák, CSc. ⁸; Oddělení nukleární medicíny a pozitronové emisní tomografie Masarykova onkologického ústavu Brno, vedoucí lékař oddělení prim. MUDr. Karol Bolčák ⁹
Published in the journal: Vnitř Lék 2009; 55(2): 147-157
Category: Case Reports

Summary

Interdigitating dendritic cell sarcoma is a rare neoplasm forming part of the group of malignancies derived from histocytic cell line. This nosological unit can be detected only by special immunohistochemical exams. A young man aged 25 found a tumorous swelling in the proximal part of his left crus. The pathological process affected proximal tibi al epiphysis and adjacent soft tissues. The first FDG-PET examination performed in the process of determining the clinical stage of the disease showed a high activity in thesite of primary tumour (SUV 7.71) and in the site of regional inguinal node (SUV 4.25). Histological examination of a diagnostic excision specimen of the tumour in the tibia and the extirpated enlarged regional nodes in the left groin led to the diagnosis of interdigitating dendritic cell sarcoma. The diagnosis was confirmed pathologically by another two centres in the Czech Republic and, due to the unusual nature of the diagnosis, also in Regensburg, Germany. Treatment started with chemotherapy, applied to patients with aggressive lymphomas in the framework of clinical studies, i.e. a combination of MegaCHOP. After 4 cycles, however, there was no visible response on the site of primary tumour. MegaCHOP therapy was therefore discontinued after the 4 cycles. Subsequently, we referred the patient for a high-dose chemotherapy with autologous bone marrow transplantation, similarly to aggressive lymphomas. The collection of blood producing stem cells from peripheral blood was successfully performed after ESHAP chemotherapy. A verificato in FDG-PET examination was performed before high-dose chemotherapy. Increased activity was detected only in left proximal crus, with an SUV of 4.6. One month after ESHAP chemotherapy, BEAM high-dose chemotherapy with autologous transplantation of blood forming tissue was performed. High-dose chemotherapy was followed up by radiotherapy targeted on the primary tumour in the crus (70 Gy). The third verificati on FDG-PET examination was performed 3 months after radiotherapy. The examination showed a continuing higher activity in the region of the primary tumour (SUV 2.69) and a new centre of activity was detected in the left inguinal nodes region (SUV 4.09). The activity corresponded to the presence of viable tumour tissue in the primary nidus and new metastases in inguinal nodes, without proofs of further proliferation at the time. Nodes of the left groin were removed. Histological examination showed affection of the node by the same type of tumour, i.e. a continuing activity of the disease despite chemotherapy. Due to suspected continuati on of viable tumour in the crus judging by the intensity of accumulation of FDG-PET and the proof of a new affection of regional nodes, surgical treatment was preferred after the failure of chemotherapy. After the removal of inguinal nodes, left knee joint exarticulati on was performed. This was followed by regional inguinal node region radiotherapy (56 Gy). The last fo urth PET- CT examination carried out 4 months after the radiation therapy of the inguinal region showed massive dissemination into the region of ileac and paraaortic nodes (lymphadenopathy up to 6 cm in diameter) with an activity of 5.9 to 6.73 SUV units. Currently, we test the sensitiveness of the disease to 2- chlorde oxyadenosin and look for additional therapeutic options. To our knowledge, the above description is the first documented case of interdigitating dendritic cell sarcoma located in the tibia and crussfot tissue. We have not fo und any description of high-dose therapy supported by autologous transplantation of blood– forming tissue for this type of tumour in relevant literature. In this case, we record chemoresistance to high-dose chemotherapy and certain radiosensitivty of the tumour at the same time.

Key words:
interdigitating dendritic cell sarcoma – high dose chemotherapy with perifepheral stem cell transplantation – FDG-PET imagination

Zdroje

1. De Pas T, Spitaleri G, Pruneri G et al. Dendritic cell sarcoma: an analytic overview of the literature and presentation of original five cases. Crit Rev Oncol Hematol 2008; 65: 1–7.

2. Kairouz S, Hashash J, Kabbara W et al. Dendritic cell neoplasms: an overview. Am J Hematol 2007; 82: 924–928.

3. Fonseca R, Tefferi A, Strickler JG. Follicular dedritic cell sarcoma mimicking diffuse large cell lymphoma. Am J Hematol 1997, 55: 148–149.

4. Fonseca R, Yamakawa M, Nakamura S et al. Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol 1998; 59: 161–167.

5. Gaertner EM, Tsokos M, Derringer GA et al. Interdigitating dendritic cell sarcoma: A report of four cases and review of the literature. Amer J Pathol 2001; 115: 589–597.

6. Barwell N, Howatson R, Jackson R et al. Interdititating dendritic cell sarcoma of solivary gland associated lymphoid tissue not associated with HHV-8 or EBV infection. J Clin Pathol 2004; 57: 87–89.

7. Cossu A, Deiana A, Lissia A et al. Synchronous interdigitating dendritic cell sarcoma and B-cell small lymphocytic lymphoma in a lymph node. Arch Pathol Lab Med 2006; 130: 544–547.

8. Feldman AL, Arber DA, Pittaluga S et al. Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood 2008; 111: 5433–5439.

9. Hangai K, Nonaka S, Iwakiri H et al. Follicular dendritic cell tumor of the cervical lymph node. ORL J Otorhinolaryngol Relat Spec 2002; 64: 229–232.

10. Jo S, Babb M, Hilsinger R. Interdigitating dendritic cell sarcoma of the cervical lymph nodes. Arch Otolaryngol Head and Neck Surg 2006; 132: 1257–1259.

11. Moz U, Pignatelli U, Forner P et al. Follicular dendritic cell tumour of the cervical lymph node: case report and brief review of literature. Acta Otorhinolaryngol Ital 2004; 24: 223–225.

12. Nakamura S, Koshikawa T, Kitoh K et al. Interdigitating cell sarcoma. A morphologic and immunohistologic study of lymph node lesions in four cases. Pathol Int 1994; 44: 374–386.

13. Rousselet MC, Francois S, Croue A et al. A lymph node reticulum cell sarcoma. Arch Path Lab Med 1994; 118: 183–184.

14. Togashi K, Shinohara H, Isoda M. Primary mediastinal lymph node malignancy with features suggestive of dendritic cell sarcoma. Jpn J Thorac Cardiovasc Surg 2005; 53: 377–381.

15. Uluoglu O, Akyurek N, Uner A et al. Interdigitating dendritic cell tumor with breast and cervical lymph-node involvement. A case report and review of the literature. Virchows Arch 2005; 446: 545–554.

16. Ylagan LD, Barlett NL, Kraus M. Interdigitating dendritic cell tumor of lymph nodes. Case report with differential diagnostic consideration. Diagn Cytopahol 2003; 28: 278–281.

17. Zivkovic V, Basic M, Gligorijevic J et al. Follicular dendritic cell sarcoma in the lymph nodes of the neck. Bratisl Lek Listy 2007; 108: 368–370.

18. Sharma M, Ahsan F, See A et al. Interdigitating dendritic cell sarcoma of the parotid gland. J Laryngoly Otology 2006; 120: 244–246.

19. Androulaki A, Giaslakiotis K, Lazaris AC. Interdigitating dendritic cell sarcoma/tumour of the tonsil. Br J Haematol 2005; 131: 415.

20. Clement P, Saint-Blancard P, Minvielle Fet al. Follicular dendritic cell sarcoma of the tonsil: a case report. Am J Otolaryngol 2006; 27: 207–210.

21. Ludwig A. Extranodal follicular dendritic cell sarcoma of the tonsils. HNO 2006; 54: 701–704.

22. McDuffie C, Lian TS, Thibodeaux J. Follicular dendritic cell sarcoma of the tonsil: a case report and literature review. Ear Nose Throat J 2007; 86: 234–235.

23. Tisch M, Hengstermann F, Kraft K et al. Follicular dendritic cell sarcoma of the tonsil: report of a rare case. Ear Nose Throat J 2003; 82: 507–509.

24. Kawachi K, Nakatani Y, Inayama Y et al. Interdigitating dendritic cell sarcoma of the spleen: report of a case with a review of the literature. Am J Surg Pathol 2002; 26: 530–537.

25. Araújo VC, Martins MT, Salmen FS et al. Extranodal follicular dendritic cell sarcoma of the palate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 209–214.

26. Biddle DA, Ro JY, Yoon GS et al. Extranodal follicular dendritic cell sarcoma of the head and neck region: three new cases, with a review of the literature. Mod Pathol 2002; 15: 50–58.

27. Domínguez-Malagón H, Cano-Valdez AM, Mosqueda-Taylor A et al. Follicular dendritic cell sarcoma of the pharyngeal region: histologic, cytologic, immunohistochemical, and ultrastructural study of three cases. Ann Diagn Pathol 2004; 8: 325–332.

28. Encabo RS, McHugh J, Carrau RL et al. Follicular dendritic cell sarcoma of the nasopharynx. Am J Otolaryngol 2008; 29: 262–264.

29. Ferringer T, Banks PM, Metcalf JS. Langerhans cell sarcoma. Am J Dermatopathol 2006; 28: 36–39.

30. Georgalas C, Kanagalingam J, Gallimore A et al. Follicular dendritic cell sarcoma arising from the hypopharynx. J Laryngol Otol 2004; 118: 317–318.

31. Gordon MK, Kraus M, van Besien K. Interdigitating dendritic cell tumors in two patients exposed to topical calcineurin inhibitors. Leuk Lymphoma 2007; 48: 816–818.

32. Pisani F, Marino M, Sentinelli S et al. Follicular dendritic cell sarcoma of the neck: report of a case treated by surgical excision and COP plus (PEG)‑liposomal doxorubicin. J Exp Clin Cancer Res 2008; 27: 33.

33. Chera BS, Orlando C, Villaret DB et al. Follicular dendritic cell sarcoma of the head and neck: case report and literature review. Laryngoscope 2008; 118: 1607–1612.

34. Ryley NG. Follicular dendritic cell sarcoma of lymph node. Cytopathology 2000; 11: 135.

35. Sahadevan K, Banerjee A, Wight R. Follicular dendritic cell sarcoma of a cervical lymph node: case report and review of the literature. Ear Nose Throat J 2004; 83: 848–849.

36. Martins MT, Witzel AL, Sugaya NN et al. Dendritic cell sarcoma of the oral cavity. Oral Oncol 2004; 40: 341–347.

37. Kanaan H, Al-Maghrabi J, Linjawi Aet al. Interdigitating dendritic sarcoma of the duodenum with rapidly fatal course. Arch Patol Lab Med 2006; 130: 205–208.

38. Banner B, Beachamp ML, Liepman M et al. Interdigitating reticulum cell sarcoma of the intestine. A case report. Diagn Cytopahtol 1997; 17: 216–222.

39. Devi S, Sunila, Siddesh G. Follicular dendritic cell tumor of mesentery – a case report. Indian J Pathol Microbiol 2004; 47: 399–401.

40. Díaz de Liaño A, Garde C et al. Intra-abdominal follicular dendritic cell sarcoma. Clin Transl Oncol 2006; 8: 837–838.

41. Yamakawa M, Andoh A, Masuda A et al. Follicular dendritic cell sarcoma of the omentum. Virchows Arch 2002; 440: 660–663.

42. Schwarz RE, Chu P, Arber DA. Extranodal follicular dendritic cell tumor of the abdominal wall. J Clin Oncol 1999; 17: 2290–2292.

43. Loo CK, Henderson C, Rogan K. Intraabdominal follicular dendritic cell sarcoma: report of a case with fine needle aspiration findings. Acta Cytol 2001; 45: 999–1004.

44. Low SE, Menasce LP, Manson CM. Follicular dendritic cell sarcoma: a rare tumor presenting as an abdominal mass. Int J Surg Pathol 2007; 15: 315–317.

45. Geerts A, Lagae E, Dhaene K et al. Metastatic follicular dendritic cell sarcoma of the stomach: a case report and review of the literature. Acta Gastroenterol Belg 2004; 67: 223–227.

46. Han JH, Kim SH, Noh SH et al. Follicular dendritic cell sarcoma presenting as a submucosal tumor of the stomach. Arch Pathol Lab Med 2000; 124: 1693–1696.

47. Chang KC, Jin YT, Chen FF et al. Follicular dendritic cell sarcoma of the colon mimicking stromal tumour. Histopathology 2001; 38: 25–29.

48. Sander B, Middel P, Gunawan B et al. Follicular dendritic cell sarcoma of the spleen. Hum Pathol 2007; 38: 668–672.

49. Jiang L, Admirand JH, Moran C et al. Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature. Ann Diagn Pathol 2006; 10: 357–362.

50. Kröber SM, Marx A, Aebert H et al. Sarcoma of follicular dendritic cells in the dorsal mediastinum. Hum Pathol 2004; 35: 259–263.

51. Leipsic JA, McAdams HP, Sporn TA. Follicular dendritic cell sarcoma of the mediastinum. AJR Am J Roentgenol 2007; 188: W554–W556.

52. Grogg KL, Lae ME, Kurtin PJ et al. Clusterin expression distinguishes follicular dendritic cell sarcoma from other dendritic cell neoplasm. Amer J Surg Pathol 2004; 28: 988–998.

53. Voigt LP, Hmidi A, Pastores SM et al. Management dilemmas due to a paratracheal follicular dendritic cell tumor. Ann Thorac Surg 2006; 82: 1898–1900.

54. Pruneri G, Masullo M, Renne G et al. Follicular dendritic cell sarcoma of the breast. Virchows Arch 2002; 441: 194–199.

55. Boldin I, Brix-Grünwald G, Scarpatetti MM et al. Interdigitating dendritic cell sarcoma of the eyelid with a rapidly fatal course. Arch Ophthalmol 2008; 126: 738–740.

56. Rupar C, Beham Schmid C, Galle G et al. Interdigitating dendritic cell sarcoma of urinary bladder mimicking large intravesical calculus. Urology 2005; 566: 1109.e1–1109.e3.

57. Luk I, Shek T, Tang V. Interdigitating dendritic cell tumor of the testis. A novel testicular spindle cell neoplasm. Amer J Surg Pathol 1999; 23: 1141–1148.

58. Pileri SA, Grogan TM, Harris NL et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002; 41: 1–29.

59. Pillay K, Salomon R, Daubenton JD et al. Interdigitating dendritic cell sarcoma. A report of four pediatric cases. Histopathology 2004; 44: 283–291.

60. Soriano AO, Thompson MA, Admirand JH et al. Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature. Am J Hematol 2007; 82: 725–728.

61. Torres U, Hawkins WG, Antonescu CR et al. Hepatic follicular dendritic cell sarcoma without Epstein‑Barr virus expression. Arch Pathol Lab Med 2005; 129: 1480–1483.

62. Krokowski M, Merz H, Thorns C et al. Sarcoma of follicular dendritic cells with features of sinus lining cells – a new subtype of reticulum cell sarcoma? Virchows Arch 2008; 452: 565–570.

63. Nayer H, Murphy KM, Hawkins AL et al. Clonal cytogenetic abnormalities and BCL2 rearrangement in interdigitating dendritic cell sarcoma. Leuk Lymphoma 2006; 47: 2651–2654.

64. Meijs M, Mekkes J, van Noesel C et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma without Castleman’s disease; treatment with rituximab. Int J Dermatol 2008; 47: 632–634.

65. Zhu X, Zhang B. Paraneoplastic pemphigus. J Dermatol 2007; 34: 503–511.

66. Diaz-Sarrio C, Salvatella–Danés N, Castro‑Forns M et al. Langerhans cell sarcoma in a patient who underwent transplantation. J Eur Acad Dermatol Venereol 2007; 21: 973–976.

67. Azim HA, Elsedewy E, Azim HA Jr. Imatinib in the treatment of follicular dendritic sarcoma: a case report and review of literature. Onkologie 2007; 30: 381–384.

68. Olnes MJ, Nicol T, Duncan M et al. Interdigitating dendritic cell sarcoma: a rare malignancy responsive to ABVD chemotherapy. Leuk Lymphoma 2002; 43: 817–821.

69. Choi JW, Lee JH, Kim A et al. Follicular dendritic cell sarcoma arising in the dura mater of the spine. Arch Pathol Lab Med 2006; 130: 1718–1721.